argenx SE reported $45M in Interest Income for its fiscal quarter ending in September of 2026.





Interest Income Change Date
AstraZeneca USD 80M 7M Jun/2026
Genmab DKK 14M 11M Mar/2026
GlaxoSmithKline GBP 58M 36M Jun/2026
GRIFOLS EUR 9.56M 4.5M Jun/2025
Hikma Pharmaceutical USD 4M 0 Dec/2024
Lakefront Biotherapeutics EUR 13.56M 991K Mar/2026
Qiagen NV USD 9.36M 1.2M Jun/2026